Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 10, 2007. The report serves as a notification of transactions involving directors and persons discharging managerial responsibility under the company's ShareReward Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on share transaction details.
- Share Price: GBP 13.17 per Ordinary share (transaction date: October 9, 2007).
- Transaction Type: Acquisitions under the ShareReward Plan (partnership and matching elements).
Material Changes
The filing details changes in share interests for four individuals: Mr. J S Heslop, Mr. R Bondy, Mr. D Learmouth, and Mr. A P Witty. Each individual acquired 10 Ordinary shares through personal contribution and 10 Ordinary shares through company matching contribution.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is a regulatory disclosure of director share purchases in accordance with Disclosure and Transparency Rules 3.1.4R(1)(a) and 3.1.4R(1)(b).
Key Facts for Investor Verification
- Four directors acquired shares on October 9, 2007, at a price of GBP 13.17.
- Each director received a total of 20 shares (10 personal, 10 matched).
- The transaction was reported to the SEC on October 10, 2007.
- No financial performance data is included in this specific filing.